BPC-157 + TB-500 Blend 15mg / 15mg

 169,00

Grail Formula Quality
BPC-157 / TB-500 15 mg / 15 mg – High Purity Research Peptide Blend.

Researched and independently verified with Liquilabs s.r.o. (Czechia).
Validated assay content 15.51 mg BPC-157 and 15.41 mg TB-500.
Endotoxins below 0.001 EU per mg. No detectable microbial growth or heavy metals.

For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.


Product Overview

BPC-157 / TB-500 is a dual-component research peptide blend studied in laboratory environments for its involvement in cellular repair signalling, tissue-response modelling and cytoskeletal interaction pathways. This lyophilized 15 mg / 15 mg preparation supports reproducible in vitro research focused on peptide-mediated communication, cellular migration models and structural response mechanisms under controlled experimental conditions.


Peptide Overview

BPC-157 is a synthetic peptide fragment derived from a naturally occurring gastric protein sequence and has been investigated since the late 1990s in research settings focused on cellular integrity, signalling stability and tissue-response modelling. TB-500, a synthetic analogue of thymosin beta-4, has been studied for its role in actin-binding dynamics, cytoskeletal organisation and cellular movement processes.

When evaluated together, this peptide combination allows researchers to explore coordinated cellular signalling behaviour, structural adaptation mechanisms and peptide-driven response patterns within regenerative and repair-oriented biochemical systems.


Historical Background and Scientific Context

From the late 1990s onward, research into peptide-mediated tissue and cellular signalling expanded rapidly as laboratories sought to better understand repair mechanisms, cytoskeletal dynamics and peptide-regulated communication pathways. Dual-peptide models combining BPC-157 and thymosin-derived peptides have since been incorporated into preclinical research frameworks investigating complex cellular response behaviour under controlled laboratory conditions.


Mechanistic Focus in Research

  • Cellular repair and response signalling modelling
  • Cytoskeletal organisation and actin-dynamics research
  • Peptide-mediated cell migration studies
  • Comparative structure–function evaluation
  • Controlled in vitro cellular response investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF112025092. Key analytical results include:

  • BPC-157 Assay Content: 15.51 mg
  • BPC-157 Identification – Retention Time: 0.997
  • TB-500 Assay Content: 15.41 mg
  • TB-500 Identification – Retention Time: 0.989
  • Endotoxins: below 0.001 EU per mg
  • Bioburden: not detected
  • Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.


Research Applications

  • Cellular repair and tissue-response research
  • Cytoskeletal and actin-dynamics studies
  • Peptide-driven cell migration modelling
  • Comparative dual-peptide pathway evaluation
  • Controlled in vitro cellular signalling investigations

Grail Formula Quality

Every Grail Formula research peptide blend undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.


When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.


Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity dual research peptide blend
Validated assay content 15.51 mg BPC-157 and 15.41 mg TB-500
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products